Key takeaways
- Dividend income crosses the border: US dividend stocks give Canadian investors access to sectors and business models that simply don’t exist on the TSX, from specialty insurance to semiconductor manufacturing to biotech, and many of these companies are growing their payouts at a pace most Canadian dividend payers can’t match.
- Growth and income aren’t exclusive: The standout names on this list aren’t just paying dividends for the sake of it. They’re backed by real earnings momentum in areas like cloud networking, gold mining, and electric vehicle infrastructure, meaning you’re not sacrificing capital appreciation potential just to collect a quarterly cheque.
- Watch withholding taxes and volatility: Canadians buying US dividend stocks face a 15% withholding tax in registered accounts like TFSAs (RRSPs get a treaty exemption), which eats into your yield. On top of that, some of these sectors, particularly gold miners and smaller industrial names, can swing hard on commodity prices or shifting government policy, so position sizing matters more than usual.
Most Canadian investors get their US exposure through an S&P 500 ETF and move on. That’s a perfectly fine approach. But it also means you’re market-cap weighting your way into a handful of mega-cap tech names and hoping for the best. If you want dividend income from US stocks specifically, the index isn’t built for that. You have to go pick individual names.
That’s what I did here, and the list surprised me. When I started screening for US dividend payers with solid fundamentals, the names that came through weren’t the usual telecom and utility suspects. I found gold miners benefiting from a massive run in the metal, a semiconductor company with a cyclical recovery story, a specialty insurer printing money, and a pharma name trading at a discount to its peers. The diversity is wild.
One thing I want to be clear about. Yield alone didn’t drive these picks. A 6% payout from a business bleeding cash is worthless. I was looking for companies where the dividend is backed by real earnings power, where the payout ratio leaves room for growth, and where the underlying business has a catalyst that goes beyond just “we’ve always paid a dividend.” Some of these yields are modest. That’s fine. Total return matters more than chasing the fattest number on a screener.
Canadians buying US dividend stocks also need to think about withholding tax. The IRS takes 15% off the top of any US dividend paid to a Canadian investor, unless you’re holding in an RRSP, where the tax treaty eliminates it. That’s a real drag in a TFSA or taxable account, and it’s something I factored into how I think about each of these names. If you’re unfamiliar with the nuances, my piece on dividend taxation covers the Canadian side in detail.
The ten companies below span gold mining, insurance, tech, healthcare, and a few others you probably wouldn’t expect on a dividend list. Some are large caps. Some are small. What they share is a combination of income and growth potential that I think makes them genuinely interesting for 2026, not just safe parking spots for capital.
In This Article
- Bristol-Myers Squibb Company (BMY)
- AT&T Inc. (T)
- Comcast Corporation (CMCSA)
- Progressive Corporation (PGR)
- Verizon Communications Inc (VZ)
- Chevron Corporation (CVX)
- Prologis Inc. (PLD)
- Philip Morris International Inc (PM)
- PepsiCo Inc. (PEP)
- Medtronic plc (MDT)
Bristol-Myers Squibb Company (NYSE: BMY)
$58.96
Overall Grade6.7 / 10
Bristol-Myers Squibb Company, established in its current form in 1989 following a merger, is a global biopharmaceutical firm operating within the healthcare sector. It focuses on developing and commercializing innovative medicines in areas such as oncology, immunology, and cardiovascular diseases...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E15.6
P/B5.9
P/S2.3
P/FCF8.5
FCF Yield+11.7%
Growth & Outlook
Rev Growth (YoY)-0.2%
EPS Growth (YoY)-178.1%
Revenue 5yr+2.5%
EPS 5yr-
FCF 5yr-
Fundamentals
Market Cap$109.8B
Dividend Yield4.3%
Operating Margin+20.7%
ROE+40.4%
Interest Coverage23.1x
Competitive Edge
- The Celgene acquisition (2019) brought Revlimid, now declining, but also Breyanzi (CAR-T) and the TYK2 franchise (deucravacitinib). The pipeline depth from that deal is still generating value years later, with Opdualag and Camzyos in early commercial ramp.
- BMY's oncology franchise (Opdivo, Yervoy, Opdualag, Breyanzi) creates deep prescriber relationships with oncologists, a channel that is notoriously sticky. Switching costs in cancer treatment are high because physicians build protocols around specific agents.
- Cardiovascular franchise diversification through Camzyos (obstructive HCM) and Milvexian (Factor XIa inhibitor in Phase 3) positions BMY in areas with limited competition and high unmet need, reducing dependence on Eliquis before its LOE.
- Manufacturing complexity of biologics like Opdivo and CAR-T therapies creates meaningful barriers to biosimilar entry compared to small molecules. Biosimilar Opdivo competition will be more limited and slower than generic Eliquis competition.
By the Numbers
- Forward P/E of 9.56x vs trailing 17.2x implies consensus expects EPS to nearly double from $3.46 to $6.24, and the PEG of 0.12 suggests the market is drastically underpricing that earnings inflection relative to growth.
- FCF-to-net-income conversion of 1.82x signals earnings quality is actually better than reported GAAP suggests. Heavy non-cash charges (amortization of acquired intangibles) are depressing reported EPS while cash generation runs at $12.8B annually.
- FCF yield of 10.6% with a FCF payout ratio of only 39% leaves substantial room for debt paydown ($4.7B implied by 4.3% debt paydown yield) while maintaining the 4.6% dividend. The company is simultaneously deleveraging and returning cash.
- Capex-to-OCF of just 9.3% and capex-to-depreciation of 0.33x show BMY is a cash machine requiring minimal reinvestment in physical assets, freeing nearly all operating cash flow for shareholders and debt reduction.
- Interest coverage of 32.4x despite $45B in total debt means refinancing risk is negligible even if rates stay elevated. The debt load looks scary in isolation but is easily serviceable against $14B+ in operating cash flow.
Risk Factors
- Consensus revenue estimates show a clear decline trajectory: $46.7B (Y1) to $36.4B (Y5), a 22% cumulative revenue erosion over five years. This is the patent cliff for Eliquis and Opdivo priced into estimates, and the Growth grade of 3/10 confirms it.
- Net debt/EBITDA of 2.46x with goodwill and intangibles comprising 69.5% of total assets means the balance sheet is loaded with acquisition-related assets. Tangible book value per share is negative $11, so equity holders own essentially a stream of future cash flows with no hard asset floor.
- Payout ratio of 71.5% on GAAP earnings looks stretched, though the 39% FCF payout ratio tells a different story. If the patent cliff compresses FCF as expected, that FCF payout ratio could quickly approach uncomfortable levels by Y3-Y4.
- Revenue has been essentially flat for three years (3Y CAGR of 1.4%) while R&D spending runs at 28.4% of revenue, roughly $13.7B annually. The return on that R&D spend needs to materialize in new product launches to offset looming LOE headwinds.
- EPS growth YoY of negative 178% reflects massive one-time charges, but even the 3Y EPS CAGR of 5.5% barely exceeds inflation. Underlying earnings power has not grown meaningfully despite billions in acquisitions.
AT&T Inc. (NYSE: T)
$26.40
Overall Grade6.3 / 10
AT&T Inc. is a diversified telecommunications company operating in wireless, broadband, video, and entertainment services...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E8.1
P/B1.6
P/S1.4
P/FCF11.1
FCF Yield+9.0%
Growth & Outlook
Rev Growth (YoY)+2.7%
EPS Growth (YoY)+104.7%
Revenue 5yr-6.1%
EPS 5yr-
FCF 5yr+27.3%
Fundamentals
Market Cap$174.8B
Dividend Yield4.2%
Operating Margin+19.2%
ROE+19.1%
Interest Coverage3.6x
Competitive Edge
- AT&T's fiber buildout creates a structural cost advantage: once passed, fiber homes cost roughly $4-5/month to maintain vs. $15-20 for legacy copper. With 10.4M fiber subs and ARPU of $72.87, each incremental fiber customer displaces a high-cost legacy connection.
- The wireless duopoly with Verizon creates pricing discipline that T-Mobile's growth strategy actually reinforces. T-Mobile targets the value segment, leaving AT&T and Verizon to compete on network quality and bundling, which supports ARPU stability in the $50-57 range.
- FirstNet, the dedicated first-responder network, provides a government-backed subscriber base with near-zero churn and guaranteed spectrum priority. This is a unique asset no competitor can replicate, embedded within the postpaid base but rarely valued separately.
- The WarnerMedia divestiture eliminated content investment risk and refocused capital allocation on network infrastructure with 15-20 year useful lives. Management's discipline in avoiding re-entry into content (unlike Verizon's past missteps) reduces strategic risk.
By the Numbers
- FCF margin of 38.5% dwarfs the net margin of 18.6%, with FCF-to-net-income conversion at 2.07x. This signals earnings quality is actually understated by GAAP, as heavy depreciation ($16.5B implied by capex-to-depreciation near 1.0x) creates a large non-cash drag that cash flow ignores.
- FCF payout ratio of just 16.9% vs. earnings payout ratio of 37.4% means the 4.6% dividend is covered over 5.9x by free cash flow. This gives enormous room for debt reduction, the real priority, while maintaining the dividend.
- Fiber broadband net adds inflected positive, with total broadband net adds surging from -24K in FY2023 to +258K in FY2024 to +729K in FY2025. Fiber now represents 70.8% of total broadband connections vs. 43.3% in FY2021, fundamentally shifting the wireline cost structure.
- At 3.96x P/FCF and 25.2% FCF yield, the market is pricing AT&T as if free cash flow will decline materially. Yet trailing unlevered FCF of $21.7B grew 28% YoY, and capex-to-OCF of 30% suggests the heavy investment cycle is moderating.
- Latin America turned from a $510M operating loss in FY2021 to a $145M profit in FY2025, a $655M swing on just $4.4B revenue. At 3.3% operating margin and accelerating, this segment is transitioning from cash drain to contributor without requiring incremental capital.
Risk Factors
- Postpaid phone churn spiked to 0.90% in FY2025 from 0.76% in FY2024, an 18.4% deterioration. Quarterly data shows sequential worsening (4.8%, 5.7%, 6.5% QoQ increases). This is the single most important leading indicator for wireless ARPU sustainability and it's moving the wrong way.
- Total mobility net adds collapsed 44.5% YoY to 2.31M, with postpaid adds down 22.8% and prepaid losing 536K subscribers. The growth engine is clearly decelerating, and reseller additions (lower-margin MVNO lines) now represent 48% of total net adds vs. essentially zero in FY2021.
- Tangible book value per share is negative $12.02, driven by intangibles comprising 46.8% of total assets and goodwill at 15.1%. This means $155B in total debt is secured against a balance sheet where nearly half the asset base is spectrum licenses and goodwill subject to impairment risk.
- Business Wireline revenue has declined every year for four straight years, accelerating from -5.8% in FY2022 to -9.9% in FY2024 before a modest improvement to -8.4% in FY2025. At $17.2B, this segment still represents 13.7% of total revenue and is a structural drag with no floor in sight.
- Net debt-to-EBITDA of 2.84x with $136.8B net debt means deleveraging to the 2.5x target requires roughly $16B in incremental debt paydown. At current FCF after dividends (~$36B FCF minus ~$8B dividends), this is achievable in roughly 18-24 months, but leaves zero room for investment shortfalls or macro shocks.
Comcast Corporation (NASDAQ: CMCSA)
$29.35
Overall Grade6.3 / 10
Comcast Corporation, founded in 1963, is a diversified telecommunications conglomerate operating primarily in the United States. The company delivers a wide range of cable, broadband, and media services across multiple business segments...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E5.6
P/B1.1
P/S0.9
P/FCF4.9
FCF Yield+20.3%
Growth & Outlook
Rev Growth (YoY)0.0%
EPS Growth (YoY)+29.4%
Revenue 5yr+3.6%
EPS 5yr+18.7%
FCF 5yr+6.7%
Fundamentals
Market Cap$107.7B
Dividend Yield4.5%
Operating Margin+16.7%
ROE+21.5%
Interest Coverage4.7x
Competitive Edge
- Comcast's broadband network is a last-mile infrastructure monopoly/duopoly in most of its footprint. Fixed wireless from T-Mobile and Verizon is taking share but cannot match cable's speed and latency at scale, preserving pricing power for now.
- Peacock reaching 44M paid subscribers (up 22% YoY) gives Comcast a direct-to-consumer asset that monetizes its NBCUniversal content library without relying solely on declining linear TV distribution fees.
- Theme Parks revenue surged 14.1% YoY to $9.8B with Epic Universe opening in Orlando in 2025. This is a high-margin, physically scarce asset that competitors cannot easily replicate and provides counter-cyclical diversification from connectivity.
- The Xfinity Mobile MVNO leverages Verizon's network with minimal capex, creating a bundling tool that reduces broadband churn. At 9.3M lines growing nearly 19% annually, it is approaching scale where it contributes meaningful standalone economics.
- Owning both content (NBCUniversal, DreamWorks) and distribution (Xfinity, Sky) creates vertical integration that allows Comcast to negotiate from strength with third-party programmers and retain exclusive content windows for Peacock.
By the Numbers
- FCF yield of 21.3% with FCF-to-net-income conversion of 1.11x signals high earnings quality. The company generates more cash than reported profits, which is rare for a media conglomerate carrying $99B in debt and heavy content spend.
- Total shareholder yield of 9.3% (4.4% dividend + 7.0% buyback + 2.2% debt paydown) at a 22% FCF payout ratio means capital returns are running at less than half of cash generation capacity. Significant room to accelerate returns or invest.
- Domestic wireless lines grew 18.9% YoY to 9.3M, adding 1.48M lines in FY2025, the fastest net add pace since FY2022. This is the only customer metric accelerating and is becoming a meaningful offset to broadband subscriber erosion.
- Connectivity & Platforms EBITDA margin expanded from 37% in FY2021 to 40% in FY2025 despite flat revenue, showing disciplined cost extraction. Average monthly revenue per customer relationship rose to $131.77, up 1.8% over two years while subs declined.
- Capex-to-depreciation of 0.73x means the company is spending well below replacement cost, harvesting its installed cable plant. This is intentional cash flow maximization from a mature asset base, directly funding the 21% FCF yield.
Risk Factors
- Domestic broadband residential net losses accelerated to -654K in FY2025 from -375K in FY2024, a 74% worsening. Total connectivity customer relationships lost 967K, nearly double the prior year. The subscriber base is in structural decline.
- Tangible book value per share is -$12.52, driven by intangibles comprising 52.6% of total assets and goodwill at 22.6%. The $1.06 P/B ratio masks that equity is entirely dependent on the assumed value of acquired media and cable assets.
- Revenue is essentially flat: 0.6% 3Y CAGR and -0.02% YoY. Yet trailing EPS of $5.39 drops to estimated $3.69 in Y1, a 31% decline. The gap between trailing and forward P/E (5.5x vs 8.1x) reflects an expected earnings reset, likely from the planned spin-off.
- Current ratio of 0.88 and quick ratio of 0.70 indicate short-term liabilities exceed liquid assets. With $99B in total debt and LT debt-to-capital at 99.4%, the balance sheet is heavily leveraged even by cable industry standards.
- Content & Experiences EBITDA fell 48.5% QoQ in the most recent quarter to $1B, while the segment's revenue grew 8.5% QoQ. This margin collapse suggests either a content write-down or heavy investment cycle that is destroying near-term segment profitability.
Progressive Corporation (NYSE: PGR)
$203.47
Overall Grade6.1 / 10
Progressive Corporation, founded in 1937, is a major U.S. insurance provider specializing in auto, home, and other property and casualty coverages...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E11.8
P/B4.4
P/S1.5
P/FCF7.8
FCF Yield+12.9%
Growth & Outlook
Rev Growth (YoY)+16.3%
EPS Growth (YoY)+60.5%
Revenue 5yr+15.5%
EPS 5yr+19.2%
FCF 5yr+17.0%
Fundamentals
Market Cap$133.4B
Dividend Yield6.8%
Operating Margin+16.5%
ROE+40.4%
Interest Coverage52.2x
Competitive Edge
- Progressive's telematics program (Snapshot) creates a proprietary data moat. With 30+ billion miles of driving data, their risk-pricing accuracy compounds over time, letting them profitably undercut competitors who rely on demographic proxies alone.
- Direct-to-consumer distribution (roughly half of personal auto) gives Progressive a structural cost advantage over agency-dependent competitors like Allstate and Travelers, enabling lower combined ratios even while spending heavily on advertising.
- The bundling strategy pairing auto with homeowners (via Progressive Home) increases customer lifetime value and reduces churn. Bundled customers lapse at roughly half the rate of mono-line policyholders, creating durable retention advantages.
- Progressive's monthly reporting of key metrics (premiums, policies, combined ratio) is unique in insurance and attracts sophisticated institutional capital. This transparency reduces information asymmetry and supports premium valuation.
- The property insurance segment's turnaround from a $238M loss in FY2022 to profitability by FY2023 demonstrates management's willingness to reprice aggressively rather than chase volume, a discipline many competitors lack.
By the Numbers
- Combined ratio improved from 95.8 in FY2022 to 88.8 in FY2024, now at 87.4 through recent quarters. That 840bps improvement translates directly to underwriting profit on a $70B+ premium base, roughly $6B in incremental pre-tax income.
- FCF-to-net-income conversion of 1.52x is exceptional for an insurer, indicating premiums collected well ahead of claims paid. This float-driven cash generation funds a $3B+ investment portfolio income stream at near-zero cost of capital.
- Personal Lines net premiums written grew 23.5% in FY2024 and 14.3% YTD in FY2025, on top of 23.3% in FY2023. Three consecutive years of 14%+ growth on a $72.6B base signals massive market share capture, not just rate increases.
- SBC-to-revenue at 0.15% is negligible, meaning virtually all reported earnings convert to real shareholder value. Compare this to tech companies running 5-15% SBC loads. Progressive's earnings quality on this dimension is pristine.
- ROE of 40.4% with minimal financial leverage (interest coverage 53x) means returns are driven by operational performance, not balance sheet engineering. This is genuine franchise-level profitability.
Risk Factors
- Consensus EPS estimates of $16.10 for Y1 vs trailing $19.23 imply a 16% earnings decline, yet the stock trades at 10.5x trailing. The forward P/E of 12.7x reveals the market already prices in normalization. The real question is whether $16 is the floor.
- Underwriting expense ratio has risen from 17.3 in FY2023 to 19.7 in FY2024 to 21.5 currently, a 240bps increase that partially offsets loss ratio gains. Growth-related acquisition costs are compressing the net benefit of better underwriting.
- Commercial Lines net premiums written declined 3.1% YTD in FY2025 after years of 8-17% growth. Quarterly data shows sequential declines of 39.9%, 5.5%, and 6.8%. This segment is actively shrinking, suggesting pricing discipline or competitive pressure.
- DCF base case target of $142 sits 29% below the current $201 price. Even the aggressive target of $155 implies 23% downside. The stock is pricing in sustained premium growth and combined ratios well below historical norms.
- Personal Lines pre-tax profit surged 137% in FY2024 to $6.84B, driven by a loss ratio drop from 77.6 to 69.1. Any reversion toward historical loss ratios (mid-70s) on the now much larger premium base would create outsized earnings compression.
Verizon Communications Inc (NYSE: VZ)
$46.78
Overall Grade6.0 / 10
Verizon Communications Inc. is a global leader in delivering communications, technology, information, and entertainment products and services...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E10.1
P/B1.6
P/S1.2
P/FCF8.5
FCF Yield+11.7%
Growth & Outlook
Rev Growth (YoY)+2.5%
EPS Growth (YoY)-2.2%
Revenue 5yr+1.5%
EPS 5yr-1.1%
FCF 5yr-1.5%
Fundamentals
Market Cap$171.8B
Dividend Yield6.1%
Operating Margin+21.2%
ROE+17.1%
Interest Coverage4.4x
Competitive Edge
- Verizon's 5G C-band spectrum holdings create a durable capacity advantage over T-Mobile in dense urban markets. Spectrum is a finite, government-allocated resource with no substitute, making it the closest thing to a permanent moat in wireless.
- Fixed wireless access is cannibalizing cable broadband (Comcast, Charter) without requiring last-mile fiber buildout. Verizon is reusing existing tower infrastructure, turning a wireless asset into a broadband competitor at fraction of traditional deployment cost.
- The 6.7% dividend yield at current prices creates a natural floor for institutional and income-oriented holders. In a declining rate environment, this yield becomes increasingly attractive relative to fixed income alternatives, compressing downside risk.
- Fios fiber footprint in the Northeast corridor serves the densest, highest-ARPU markets in the U.S. Unlike cable competitors facing fiber overbuild risk, Verizon already owns the fiber, giving it structural cost advantages in its served territories.
- Wireless industry consolidation to three national carriers (Verizon, T-Mobile, AT&T) creates rational pricing discipline. DISH/EchoStar remains a weak fourth player, reducing the risk of a price war that would compress industry margins.
By the Numbers
- PEG of 0.49 against a forward P/E of 10.3x signals the market is underpricing Verizon's estimated EPS growth from $4.06 trailing to $4.91 in Y1 and $5.21 in Y2, a 21% and 28% cumulative increase that the valuation barely reflects.
- FCF yield of 9.6% with FCF-to-net-income conversion of 1.14x indicates earnings quality is strong. Cash generation exceeds reported profits, meaning the income statement actually understates economic earnings power.
- Consumer broadband connections grew 8.4% YoY to 10.86M, the fastest-growing KPI in the portfolio. This fixed wireless access ramp is layering a second revenue stream onto existing wireless infrastructure with minimal incremental capex.
- Consumer ARPA grew from $122.30 in FY2021 to $138.25 in FY2024, a 13% cumulative increase, while postpaid connections grew only 3.9% over the same period. Monetization per account is doing the heavy lifting, not subscriber volume.
- Capex-to-depreciation of 0.93x means Verizon is spending less on capex than it depreciates, suggesting the C-band buildout cycle is peaking. As capex normalizes lower, FCF should expand even on flat revenue.
Risk Factors
- Net debt of $162.6B at 2.93x EBITDA with interest coverage of only 7.1x leaves thin margin for error. At current OCF-to-debt of 23.4%, it would take over 4 years of entire operating cash flow to retire total debt, and that ignores dividends and capex.
- EPS has declined at a -7.1% 3-year CAGR and -1.1% over 5 years despite stable revenue, meaning margin compression and rising interest expense are eating into profitability. The Growth grade of 3.6/10 confirms this structural weakness.
- Consumer wireless postpaid net adds fell 56.8% YoY to 581K in FY2025 while Q3 showed a sharp QoQ decline before a Q4 surge. The volatility suggests promotional dependency rather than organic demand, and the annual trend is clearly decelerating from the 2.04M peak in FY2023.
- Business segment revenue has declined for four consecutive years, from $31.07B in FY2022 to $29.07B in FY2025, a cumulative 6.4% erosion. Business operating income fell 26% from FY2021 to FY2024 before a partial bounce. This segment is structurally shrinking.
- Tangible book value per share is negative $20.30, driven by intangibles comprising 47% of total assets. The $181.6B debt load sits on top of a balance sheet where nearly half the assets are spectrum licenses and goodwill, assets that cannot be easily liquidated.
Chevron Corporation (NYSE: CVX)
$188.15
Overall Grade5.6 / 10
Chevron Corporation is a global integrated energy company operating across the oil, natural gas, and petrochemical sectors. Originally founded in 1879 as the Pacific Coast Oil Co., it has grown to become one of the world’s largest energy firms with a significant international presence...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E22.9
P/B1.6
P/S1.6
P/FCF18.3
FCF Yield+5.5%
Growth & Outlook
Rev Growth (YoY)-4.6%
EPS Growth (YoY)-31.5%
Revenue 5yr+14.3%
EPS 5yr-
FCF 5yr+22.8%
Fundamentals
Market Cap$304.0B
Dividend Yield3.8%
Operating Margin+8.9%
ROE+7.2%
Interest Coverage13.4x
Competitive Edge
- The Hess acquisition added Guyana's Stabroek block, one of the highest-return deepwater assets globally with breakevens below $35/bbl. This gives CVX a decade-plus growth runway in a basin where ExxonMobil is the only comparable operator.
- CVX's integrated model provides a natural hedge: when crude prices fall, refining margins often expand as input costs drop. FY2025's downstream recovery while upstream earnings declined demonstrates this countercyclical offset in real time.
- Permian Basin position as the second-largest acreage holder behind ExxonMobil provides low-decline, high-return inventory that generates cash even at $50 WTI. Short-cycle shale investment can flex quickly with commodity prices.
- Chevron's LNG portfolio, including Gorgon, Wheatstone, and equity in global projects, positions it for structural demand growth as Asian and European buyers seek long-term gas supply security post-Russia sanctions.
- Minimal goodwill at 1.4% of assets means the balance sheet carries almost no acquisition impairment risk despite the Hess deal, likely because Hess was structured to avoid massive goodwill creation through reserve-based purchase accounting.
By the Numbers
- Total upstream production surged 11.5% YoY to 3,723 MBOED in FY2025, with U.S. production up 16.2% to 1,858 MBOED. This volume growth is clearly Hess-acquisition driven and gives CVX a structurally higher production base even if commodity prices weaken.
- FCF-to-net-income ratio of 1.33x indicates earnings quality is solid, with cash generation exceeding reported profits. OCF-to-net-income at 2.72x confirms strong non-cash charge coverage and real cash backing behind reported earnings.
- Interest coverage at 30x with net debt/EBITDA under 1.0x gives CVX significant financial flexibility during a commodity downturn. Even if EBITDA halved, coverage would remain comfortable, a critical advantage in a cyclical business.
- Downstream segment earnings rebounded 75% YoY to $3.0B in FY2025 after collapsing 72% in FY2024, while downstream capex was cut 45% YoY. This margin recovery on lower investment suggests refining crack spreads are normalizing, not that CVX is spending its way to growth.
- Buyback yield of 5.0% combined with 4.5% dividend yield delivers nearly 9.5% total cash return. With capex/OCF at 51%, roughly half of operating cash flow is available for shareholder returns even at current spending levels.
Risk Factors
- Payout ratio at 103.7% of earnings means CVX is paying more in dividends than it earns. While FCF payout at 77% is more sustainable, any further commodity price decline compresses FCF and puts the dividend commitment under real pressure.
- Upstream U.S. earnings fell 23.5% YoY and upstream international earnings dropped 36.3% in FY2025, despite production volumes rising 16%. This means realized prices and margins per barrel are deteriorating sharply, masking the volume growth story.
- EPS has declined at a negative 28.7% 3-year CAGR while FCF contracted at a negative 32.1% 3-year CAGR. The trailing P/E of 30x on trough-ish earnings looks optically cheap only if you assume a strong commodity recovery that consensus estimates require.
- Capex-to-depreciation at 0.86x means CVX is spending less than its depreciation charge, essentially underinvesting relative to asset base depletion. This flatters near-term FCF but raises questions about reserve replacement and long-term production sustainability.
- The 'All Other' segment losses widened 33% YoY to negative $3.5B in FY2025. This corporate drag, likely including new energy ventures and overhead, is growing faster than any profit center and quietly eroding consolidated returns.
Prologis Inc. (NYSE: PLD)
$142.17
Overall Grade5.6 / 10
Prologis Inc. is a global leader in industrial real estate, specializing in the ownership, development, and management of logistics facilities...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E36.0
P/B2.2
P/S13.5
P/FCF88.7
FCF Yield+1.1%
Growth & Outlook
Rev Growth (YoY)+7.2%
EPS Growth (YoY)-11.3%
Revenue 5yr+14.6%
EPS 5yr+11.9%
FCF 5yr-
Fundamentals
Market Cap$118.6B
Dividend Yield3.0%
Operating Margin+38.8%
ROE+6.1%
Interest Coverage3.4x
Competitive Edge
- Prologis controls ~1.2B square feet globally in irreplaceable infill logistics locations near major population centers. Zoning restrictions and land scarcity in these markets create a physical barrier to entry that no competitor, including Blackstone's logistics funds, can easily replicate.
- The strategic capital platform (co-investment vehicles) lets Prologis earn fees on $100B+ of third-party AUM while retaining operational control. This is an asset-light earnings stream with embedded promote structures that pay out during strong markets.
- Amazon, FedEx, DHL, and other top tenants have multi-year lease commitments with 3-4% annual escalators baked in. These contractual rent bumps provide organic same-store NOI growth even in a flat demand environment.
- The shift to nearshoring and supply chain redundancy post-COVID structurally increases demand for warehouse space in the U.S. and Mexico, where Prologis has dominant market share. This is a multi-year secular tailwind, not a one-time adjustment.
- Prologis has an estimated 30-40% mark-to-market rent spread embedded in its in-place leases versus current market rents. As leases roll over the next 3-5 years, this translates to organic rental revenue growth independent of new development.
By the Numbers
- Core FFO grew to $5.56B in FY2025, up 4.8% YoY after a flat FY2024, with the 3Y CAGR still at ~10%. For a REIT of this scale, FFO is the real earnings metric, and the reacceleration after a pause year signals the rent roll-up cycle is gaining traction again.
- Rental revenue grew 8.6% YoY to $8.16B, now representing 93% of total revenue vs. 87% in FY2021. This mix shift toward pure rental income reduces earnings volatility from lumpy strategic capital gains and development fees.
- Property NOI margin improved to ~76% of rental revenue ($6.19B on $8.16B), up from ~76.5% prior year, holding steady despite occupancy dipping to 95.8%. Embedded mark-to-market rent spreads are offsetting the occupancy drag.
- Occupancy stabilized at 95.8% in Q4 2025 after declining from 98.2% in FY2022, with quarterly sequential improvement of +0.5% in Q4. The trough appears to be forming, which is a leading indicator for NOI reacceleration.
- SG&A at just 5.3% of revenue is exceptionally lean for a company managing 5,440 properties and 1.2B+ square feet, reflecting operating scale that smaller industrial REITs cannot replicate.
Risk Factors
- Net debt/EBITDA at 5.6x is elevated for an industrial REIT, and with interest coverage at only 6.0x, refinancing $35B in total debt into a higher-rate environment could compress FFO per share by 3-5% depending on maturity timing.
- The GAAP payout ratio of 113% and FCF payout ratio of 290% are alarming on the surface. While REITs fund dividends from FFO not GAAP earnings, the FCF payout shows capex is consuming nearly all operating cash flow, leaving the dividend dependent on external capital markets.
- Capex/OCF at 73% and capex/depreciation at 1.4x indicate Prologis is spending well above maintenance levels. If development yields compress or leasing slows, this aggressive capital deployment becomes a drag rather than a growth engine.
- Strategic Capital revenue declined 44% in FY2024 and another 11.8% in FY2025, with NOI from this segment dropping from $815M to $322M over two years. This high-margin, asset-light fee stream is shrinking as transaction volumes remain depressed.
- Current ratio of 0.58 signals near-term liquidity tightness. While REITs typically rely on revolving credit facilities rather than current assets, this leaves little buffer if capital markets seize up during a refinancing window.
Philip Morris International Inc (NYSE: PM)
$156.24
Overall Grade5.6 / 10
Philip Morris International Inc. is a global tobacco company that manufactures, markets, and sells cigarettes and alternative nicotine delivery products...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E22.1
P/B-25.0
P/S6.1
P/FCF23.4
FCF Yield+4.3%
Growth & Outlook
Rev Growth (YoY)+7.3%
EPS Growth (YoY)+61.2%
Revenue 5yr+7.2%
EPS 5yr+7.1%
FCF 5yr+2.8%
Fundamentals
Market Cap$249.7B
Dividend Yield3.8%
Operating Margin+36.6%
ROE-140.3%
Interest Coverage15.4x
Competitive Edge
- IQOS heated tobacco creates a razor/blade model with device lock-in and consumable repurchase. Once users invest in the device ecosystem and adapt their habits, switching costs are materially higher than traditional cigarettes.
- PM's smoke-free portfolio spans three distinct categories: heated tobacco (IQOS), nicotine pouches (ZYN), and oral tobacco. This diversification within reduced-risk products hedges against any single regulatory or competitive threat.
- The Swedish Match acquisition gave PM direct U.S. distribution infrastructure and the ZYN brand, effectively re-entering the American market it was excluded from since the 2008 Altria spinoff. This is a structural expansion of addressable market.
- Excise tax structures in most markets are calibrated to combustible cigarettes, giving heated tobacco and pouches a relative tax advantage. As regulators increasingly differentiate by harm reduction, PM's portfolio is positioned on the right side of policy.
- PM operates in 180+ markets with no single country exceeding 15% of revenue. This geographic diversification insulates against any one regulatory shock, unlike Altria's pure U.S. exposure or Japan Tobacco's Japan concentration.
By the Numbers
- ROIC of 28.4% against 18.5% ROA shows the business generates exceptional returns on invested capital despite negative equity from legacy buybacks, confirming genuine operating efficiency rather than financial engineering.
- Smoke-free products revenue grew from $9.3B in FY2021 to $16.9B in FY2025, a 16% CAGR, now representing 41% of total revenue vs. 30% four years ago. This mix shift toward higher-growth categories is the core re-rating story.
- ZYN U.S. shipment volumes compounded at roughly 46% annually over four years, reaching 794M cans in FY2025. This single product line is likely generating $2B+ in revenue and is the fastest-growing nicotine brand in the U.S. market.
- FCF-to-net-income conversion of 0.90x with OCF-to-net-income at 1.03x confirms high earnings quality. Capex at just 3.9% of revenue and 12.8% of OCF means the business is inherently capital-light despite manufacturing operations.
- Interest coverage at 17.5x is extremely comfortable for a company carrying $49B in total debt, meaning debt service consumes under 6% of EBIT. This gives PM significant financial flexibility despite the leveraged balance sheet.
Risk Factors
- FCF growth has been flat to negative over 3 years (negative 1.2% CAGR) even as revenue grew 8.6% CAGR, suggesting working capital or investment absorption. The 219-day cash conversion cycle, driven by 286 days inventory outstanding, is the culprit.
- Americas operating income collapsed from $548M in FY2024 to $505M in FY2025, and the most recent quarter showed just $8M, a 75% QoQ decline. ZYN capacity buildout and promotional spending are crushing near-term profitability in this key growth region.
- FCF payout ratio at 81% leaves minimal cushion for the $5.54/share dividend. With zero buyback yield and slightly negative debt paydown yield, total shareholder yield is actually negative 0.6%, meaning the company is net consuming capital.
- Revenue growth ex-FX/ex-acquisitions decelerated from 10.1% in FY2024 to 6.5% in FY2025, and the most recent quarter showed just 3.7%. Organic momentum is fading right as the stock trades near all-time highs.
- Tangible book value per share is negative $24.48, reflecting $49B in debt against $28B in intangibles and goodwill (41% of assets). Any impairment of the Swedish Match acquisition goodwill would further erode an already deeply negative equity base.
PepsiCo Inc. (NASDAQ: PEP)
$158.38
Overall Grade5.4 / 10
PepsiCo Inc., founded in 1898 and restructured in 1965, is a global multinational operating in the food, snack, and beverage industry. It serves consumers in over 200 countries with a wide-ranging portfolio of products...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E24.0
P/B9.6
P/S2.1
P/FCF25.6
FCF Yield+3.9%
Growth & Outlook
Rev Growth (YoY)+2.3%
EPS Growth (YoY)-13.7%
Revenue 5yr+5.9%
EPS 5yr+3.2%
FCF 5yr+4.6%
Fundamentals
Market Cap$196.5B
Dividend Yield3.6%
Operating Margin+12.2%
ROE+42.8%
Interest Coverage10.3x
Competitive Edge
- PepsiCo's dual food-and-beverage model creates unique distribution synergies. Frito-Lay's direct-store-delivery network covers over 300,000 U.S. retail locations, giving snack brands shelf-space control that Mondelez, Kellanova, and pure-play competitors cannot replicate at comparable cost.
- The FY2025 segment reorganization (merging Frito-Lay and Quaker into PFNA, creating IB Franchise) signals management is optimizing for margin extraction and accountability. Consolidating the struggling Quaker business under Frito-Lay's stronger management team could accelerate the recall recovery.
- PepsiCo's franchise-based international beverage model (IB Franchise segment grew operating profit 21% YoY) is asset-light and high-margin. This structure mirrors Coca-Cola's bottler refranchising playbook, reducing capital intensity while capturing concentrate economics.
- Category positioning in salty snacks is structurally advantaged. Frito-Lay holds ~60% U.S. market share in salty snacks, a category with high impulse-purchase frequency, low private-label penetration, and minimal GLP-1 drug exposure compared to sugary beverages or confections.
- Emerging market food platforms in Latin America and Asia Pacific provide long-duration growth runways. LatAm Foods generates 19% operating margins on $10.5B revenue, and the category benefits from rising snacking occasions as developing-market consumers shift toward packaged convenience foods.
By the Numbers
- PEG ratio of 0.41 is striking given forward P/E of 18.1x, implying consensus expects ~44% EPS growth from trailing $6.00 to $8.63 in Y1. That gap between trailing and forward earnings suggests FY2025 had significant one-time charges depressing the $6 trailing EPS figure.
- ROIC of 13.5% comfortably exceeds PepsiCo's weighted average cost of capital (likely 7-8%), confirming the business still creates real economic value despite 2.4x debt/equity. The 42.8% ROE is amplified by leverage but the underlying asset productivity at 9% ROA is solid for consumer staples.
- Negative cash conversion cycle of -124 days is a massive working capital advantage. PepsiCo collects from customers and turns inventory far faster than it pays suppliers (DPO of 213 days), effectively using vendor financing to fund operations and reduce capital needs.
- SBC/revenue at just 0.3% is negligible, meaning reported margins closely approximate true cash economics. Unlike tech peers, virtually no hidden dilution cost is embedded in the P&L, and buybacks (0.43% yield) are genuinely returning capital rather than offsetting option grants.
- FCF-to-net-income conversion of 0.92x is healthy, and OCF-to-net-income of 1.46x shows strong cash generation above reported earnings. Capex/depreciation at 1.06x means the company is roughly maintaining its asset base without overinvesting, keeping free cash flow clean.
Risk Factors
- FCF payout ratio at 99.8% leaves essentially zero margin of safety for the dividend. With $5.58 FCF per share and $5.58 dividend per share, any modest decline in free cash flow forces either dividend cuts or incremental borrowing to maintain the payout.
- Total organic volume declined 2% company-wide in FY2025 while net pricing grew 4%, meaning 100% of organic revenue growth came from price increases. This pricing-over-volume dynamic has persisted for three years and raises demand elasticity risk as consumer pushback builds.
- PBNA segment operating profit collapsed 52.7% YoY to $1.09B despite revenue growing 1.5%. Operating margin cratered from ~8.3% to ~3.9%, suggesting either a major restructuring charge, competitive pricing pressure, or cost inflation that management couldn't offset in the beverage business.
- Tangible book value per share is negative at -$9.89, with intangibles/goodwill comprising 31.6% of total assets. The 10.3x P/B multiple rests entirely on brand value and earnings power. Any impairment to the $17.6B goodwill balance would directly hit equity.
- Current ratio of 0.85 and quick ratio of 0.64 indicate short-term liabilities exceed liquid assets. While common for consumer staples with strong cash flows, combined with net debt/EBITDA of 2.5x and $49B total debt, refinancing risk is non-trivial if credit markets tighten.
Medtronic plc (NYSE: MDT)
$85.65
Overall Grade5.3 / 10
Medtronic plc is a global medical technology company founded in 1949 that develops and manufactures innovative therapies and devices for the health care sector. It operates across multiple therapeutic areas with a core focus on improving patient outcomes and quality of life...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E28.1
P/B2.6
P/S3.6
P/FCF23.9
FCF Yield+4.2%
Growth & Outlook
Rev Growth (YoY)+2.1%
EPS Growth (YoY)-3.2%
Revenue 5yr+2.2%
EPS 5yr+0.7%
FCF 5yr-1.7%
Fundamentals
Market Cap$129.3B
Dividend Yield3.3%
Operating Margin+17.0%
ROE+9.5%
Interest Coverage8.5x
Competitive Edge
- MDT's installed base of implantable devices (pacemakers, spinal stimulators, insulin pumps) creates recurring revenue through replacements, consumables, and software upgrades. Switching costs are enormous because physicians train on specific platforms and hospitals integrate with MDT's data systems.
- The 780G insulin pump with Guardian 4 sensor has recaptured share from Insulet and Dexcom/Tandem, driving the diabetes turnaround. FDA clearance in the U.S. and international expansion give MDT a competitive product for the first time in years in this high-growth category.
- Regulatory moats in medtech are real: FDA 510(k) and PMA pathways create 2-5 year barriers for competitors on each product. MDT's breadth across cardiac, neuro, spine, and surgical means it can bundle procurement contracts that smaller competitors cannot match.
- Hugo robotic surgical system positions MDT against Intuitive Surgical's da Vinci monopoly. While still early, MDT's existing hospital relationships and service infrastructure give it a distribution advantage that pure-play robotics entrants lack.
- Geographic diversification is genuine: 51% U.S., 30% developed international, 18% emerging markets. Emerging markets grew 6.5% in FY2025 and represent the highest structural growth runway as procedure volumes expand in China, India, and Southeast Asia.
By the Numbers
- PEG of 0.27 is striking: forward PE of 15.66x against consensus EPS growth from $5.65 to $7.78 over five years implies ~7.8% CAGR, yet the market prices MDT like a no-growth utility. The gap between trailing PE (24.3x) and forward PE (15.66x) signals a 55% earnings step-up already baked into estimates.
- Diabetes segment is the hidden accelerator: 11.5% organic growth in FY2025 with operating profit surging 24.6% YoY to $491M. Margins are inflecting as the 780G system gains share, and this segment's profit contribution is still only ~4% of total, meaning upside is asymmetric.
- FCF-to-net-income conversion of 1.17x confirms high earnings quality. OCF-to-net-income at 1.57x with capex/OCF at just 25.7% shows the business generates real cash well above reported earnings, a rarity for a company with $28B in debt.
- Cardiovascular organic growth accelerated from 4% to 5% to 6.3% over FY2023-FY2025, the strongest three-year trend in the portfolio. With the segment now 37% of revenue and margins expanding (operating profit +7.3% on +5.5% revenue), this is genuine operating leverage.
- Current ratio of 2.54 and cash ratio of 0.88 are unusually strong for a $129B medtech company carrying $28B debt. With $8.3B cash and $7.3B OCF, MDT could retire all net debt in under 2.7 years from free cash flow alone.
Risk Factors
- Medical Surgical organic growth collapsed from 4.7% in FY2024 to 0.8% in FY2025, yet this segment still represents 25% of revenue. Operating profit fell 4% YoY despite flat revenue, signaling margin pressure. Surgical & Endoscopy revenue was essentially flat at -0.2%.
- Goodwill at 45.8% of total assets and intangibles at 57.1% leave tangible book value per share at negative $2.52. The $2.29 P/B ratio is meaningless when the tangible equity is wiped out, meaning shareholders are entirely dependent on earnings power with zero asset floor.
- Payout ratio of 78.6% on earnings and 67.4% on FCF leaves minimal cushion. With only ~$1.7B of FCF remaining after dividends ($3.6B) and buybacks ($0.4B), there is almost no financial flexibility for bolt-on acquisitions without incremental debt.
- Revenue per share grew from ~$25.5 (implied 5Y ago) to $27.55, a 1.6% CAGR, while reported revenue grew 2.2% CAGR over 5 years. Share dilution consumed roughly 27% of top-line growth, despite buyback yield of 0.31%. SBC is modest at 1.3% of revenue but buybacks barely offset it.
- Cash conversion cycle of 173 days is extremely long, driven by 182 days inventory on hand. Inventory turnover of 2.0x suggests either product complexity or demand softness. DIO this elevated in medtech warrants monitoring for obsolescence risk on older device platforms.
I’ll be honest, this group challenges the lazy assumption that US dividend investing means buying slow-growing blue chips and clipping coupons. Half of these names have real growth stories attached to them, and the dividend is almost secondary to the capital appreciation potential. That’s the kind of setup I gravitate toward. A company paying you while the business is actually getting better is a fundamentally different proposition than one paying you because it has nothing else to do with the cash.
The mix here also forces you to think about what kind of income investor you actually are. Some of these are stable compounders. Others are cyclical and will test your patience. Knowing which category each name falls into before you buy is the difference between holding with conviction and panic-selling after a rough quarter.
Pick the ones where the business makes sense to you first. The dividend follows from that.
